Diet, micronutrients, and arsenic methylation Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, et al. 2006. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 84(5):1093–1101. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, et al. 2005. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113:1683–1688. Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, et al. 1998. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 27(5):871–877. Hall MN, Liu X, Slavkovich V, Ilievski V, Pilsner JR, Alam S, et al. 2009. Folate, cobalamin, cysteine, homocysteine, and arsenic metabolism among children in Bangladesh. Environ Health Perspect 117:825–831. Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman DA, Smith MM, et al. 2003. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 14(2):174–182. Healy SM, Zakharyan RA, Aposhian HV. 1997. Enzymatic methylation of arsenic compounds. IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethy- larsonic acid in the guinea pig. Mutat Res 386(3):229–239. Heck JE, Gamble MV, Chen Y, Graziano JH, Slavkovich V, Parvez F, et al. 2007. Consumption of folate-related nutri- ents and metabolism of arsenic in Bangladesh. Am J Clin Nutr 85(5):1367–1374. Heck JE, Nieves JW, Chen Y, Parvez F, Brandt-Rauf PW, Graziano JH, et al. 2009. Dietary intake of methionine, cysteine, and protein and urinary arsenic excretion in Bangladesh. Environ Health Perspect 117:99–104. Hopenhayn C, Huang B, Christian J, Peralta C, Ferreccio C, Atallah R, et al. 2003. Profile of urinary arsenic metabolites during pregnancy. Environ Health Perspect 111:1888–1891. Hopenhayn-Rich C, Biggs ML, Kalman DA, Moore LE, Smith AH. 1996a. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect 104:1200–1207. Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. 1996b. Methylation study of a population environmen- tally exposed to arsenic in drinking water. Environ Health Perspect 104:620–628. Hsueh YM, Chung CJ, Shiue HS, Chen JB, Chiang SS, Yang MH, et al. 2009. Urinary arsenic species and CKD in a Taiwanese population: a case-control study. Am J Kidney Dis 54(5):859–870. Huang YL, Hsueh YM, Huang YK, Yip PK, Yang MH, Chen CJ. 2009. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis- hyperendemic areas in southwestern Taiwan. Sci Total Environ 407(8):2608–2614. Hughes MF. 2002. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 133(1):1–16. Larsen K. 1972. Creatinine assay by a reaction-kinetic principle. Clin Chim Acta 41:209–217. Lin S, Cullen WR, Thomas DJ. 1999. Methylarsenicals and arsi- nothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem Res Toxicol 12(10):924–930. Lin S, Del Razo LM, Styblo M, Wang C, Cullen WR, Thomas DJ. 2001. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem Res Toxicol 14(3):305–311. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ, et al. 2001. Methylated trivalent arsenic spe- cies are genotoxic. Chem Res Toxicol 14(4):355–361. Mishra VK, Retherford RD, Smith KR. 1999. Biomass cooking fuels and prevalence of tuberculosis in India. Int J Infect Dis 3(3):119–129. Mitra SR, Mazumder DN, Basu AR, Block GS, Haque R, Samanta S, et al. 2004. Nutritional factors and susceptibil- ity to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect 112:1104–1109. Mudd SH, Poole JR. 1975. Labile methyl balances for normal humans on various dietary regimens. Metabolism 24(6):721–735. National Research Council. 1999. Arsenic in drinking water. Washington DC:National Academy Press. National Research Council. 2001. Arsenic in drinking water: 2001 update. Washington, DC:National Academy Press. Nermell B, Lindberg AL, Rahman M, Berglund M, Persson LA, El Arifeen S, et al. 2008. Urinary arsenic concentration adjust- ment factors and malnutrition. Environ Res 106(2):212–218. Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Vasken Aposhian H. 2000. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163(2):203–207. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, et al. 2009. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect 117:254–260. Poirier LA, Wise CK, Delongchamp RR, Sinha R. 2001. Blood determinations of S-adenosylmethionine, S-adenosyl- homocysteine, and homocysteine: correlations with diet. Cancer Epidemiol Biomarkers Prev 10(6):649–655. Steinmaus C, Carrigan K, Kalman D, Atallah R, Yuan Y, Smith AH. 2005. Dietary intake and arsenic methylation in a U.S. population. Environ Health Perspect 113:1153–1159. Steinmaus C, Yuan Y, Bates MN, Smith AH. 2003. Case-control study of bladder cancer and drinking water arsenic in the Western United States. Am J Epidemiol 158(12):1193–1201. Steinmaus C, Yuan Y, Liaw J, Smith AH. 2009. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis. Epidemiology 20(6):807–815. Styblo M, Del Razo LM, LeCluyse EL, Hamilton GA, Wang C, Cullen WR, et al. 1999. Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem Res Toxicol 12(7):560–565. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, et al. 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74(6):289–299. Styblo M, Thomas DJ. 1997. Factors influencing in vitro methylation of arsenical in rat liver cytosol. In: Arsenic Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). New York:Chapman & Hall, 283–295. Environmental Health Perspectives • volume 119 | number 9 | September 2011 1313